Literature DB >> 3420556

Relation of perceived nasal and bronchial hyperresponsiveness to FEV1, basophil counts, and methacholine response.

F Kauffmann1, F Neukirch, I Annesi, M Korobaeff, M F Doré, J Lellouch.   

Abstract

Perceived nasal and bronchial hyperresponsiveness to tobacco smoke and cold air were assessed in 912 working men in the Paris area. Baseline lung function measurements and peripheral leucocyte counts with standard differential counts were performed. At least one perceived nasal or bronchial hyperresponsiveness symptom was reported by 15.7%. Current smoking was significantly less frequent among those with cough induced by tobacco smoke. Rhinitis induced by cold air was associated with lower FEV1 (p less than 0.01) and the association remained after adjustment for smoking, asthma, and wheezing (p = 0.06). Symptoms induced by cold air were related to circulating basophils. Neither perceived nasal nor perceived bronchial hyperresponsiveness was significantly related to the airway response to methacholine in a sample of the group (n = 324) surveyed again five years later. The result suggest that the symptom of rhinitis provoked by cold air is a possible "new" risk factor or marker for chronic airflow limitation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3420556      PMCID: PMC461310          DOI: 10.1136/thx.43.6.456

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  Respiratory symptoms and bronchial reactivity.

Authors:  I Annesi; F Neukirch; E Orvoen-Frija; M P Oryszczyn; M Korobaeff; F Kauffman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

Review 2.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Smoking, allergy and airways obstruction: revival of the 'Dutch hypothesis'.

Authors:  N Pride
Journal:  Clin Allergy       Date:  1986-01

4.  Atopy, non-allergic bronchial reactivity, and past history as determinants of work related symptoms in seasonal grain handlers.

Authors:  W O Cookson; G Ryan; S MacDonald; A W Musk
Journal:  Br J Ind Med       Date:  1986-06

5.  Eosinophils, smoking, and lung function. An epidemiologic survey among 912 working men.

Authors:  F Kauffmann; F Neukirch; M Korobaeff; M J Marne; J R Claude; J Lellouch
Journal:  Am Rev Respir Dis       Date:  1986-12

6.  Pneumococcus-specific immunoglobulin E in cigarette smokers.

Authors:  J W Bloom; M Halonen; A M Dunn; J L Pinnas; B Burrows
Journal:  Clin Allergy       Date:  1986-01

Review 7.  Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers.

Authors:  N B Pride; R G Taylor; T K Lim; H Joyce; A Watson
Journal:  Bull Eur Physiopathol Respir       Date:  1987 Jul-Aug

8.  Selection effects of repeatability criteria applied to lung spirometry.

Authors:  E A Eisen; J M Robins; I A Greaves; D H Wegman
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

9.  Increased levels of airways responsiveness as a risk factor for development of chronic obstructive lung disease. What are the issues?

Authors:  S T Weiss; F E Speizer
Journal:  Chest       Date:  1984-07       Impact factor: 9.410

10.  Relationships between functional measurements and childhood respiratory diseases according to the age of onset.

Authors:  F Kauffmann; F Neukirch; J P Martin; J R Claude
Journal:  Eur J Respir Dis       Date:  1987-02
View more
  4 in total

Review 1.  Upper airways reactions to cold air.

Authors:  Alvaro A Cruz; Alkis Togias
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

2.  Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.

Authors:  Michel Laviolette; David L Gossage; Gail Gauvreau; Richard Leigh; Ron Olivenstein; Rohit Katial; William W Busse; Sally Wenzel; Yanping Wu; Vivekananda Datta; Roland Kolbeck; Nestor A Molfino
Journal:  J Allergy Clin Immunol       Date:  2013-07-16       Impact factor: 10.793

3.  Recent developments in United airways disease.

Authors:  Giorgio Ciprandi; Davide Caimmi; Michele Miraglia Del Giudice; Mario La Rosa; Carmelo Salpietro; Gian Luigi Marseglia
Journal:  Allergy Asthma Immunol Res       Date:  2012-02-08       Impact factor: 5.764

Review 4.  Benralizumab: a unique IL-5 inhibitor for severe asthma.

Authors:  Laren D Tan; Jennifer M Bratt; Dorottya Godor; Samuel Louie; Nicholas J Kenyon
Journal:  J Asthma Allergy       Date:  2016-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.